Cell Biology Department, National Research Centre, 33 El Bohouth, St., P.O.12622, Dokki, Giza, Egypt.
Mol Biol Rep. 2022 Oct;49(10):10039-10050. doi: 10.1007/s11033-022-07572-1. Epub 2022 May 24.
Antimicrobial peptides (AMPs) are a diverse class of molecules that represent a vital part of innate immunity. AMPs are evolutionarily conserved molecules that exhibit structural and functional diversity. They provide a possible solution to the antibiotic-resistance crisis.
These small cationic peptides can target bacteria, fungi, and viruses, as well as cancer cells. Their unique action mechanisms, rare antibiotic-resistant variants, broad-spectrum activity, low toxicity, and high specificity encourage pharmaceutical industries to conduct clinical trials to develop them as therapeutic drugs. The rapid development of computer-assisted strategies accelerated the identification of AMPs. The Antimicrobial Peptide Database (APD) so far contains 3324 AMPs from different sources. In addition to their applications in different fields, some AMPs demonstrated the potential to combat COVID-19, and hinder viral infectivity in diverse ways.
This review provides a brief history of AMPs and their features, including classification, evolution, sources and mechanisms of action, biosynthesis pathway, and identification techniques. Furthermore, their different applications, challenges to clinical applications, and their potential use against COVID-19 are presented.
抗菌肽 (AMPs) 是一类多样化的分子,代表着先天免疫的重要组成部分。AMPs 是进化上保守的分子,具有结构和功能的多样性。它们为解决抗生素耐药性危机提供了一种可能的解决方案。
这些小阳离子肽可以靶向细菌、真菌、病毒以及癌细胞。它们独特的作用机制、罕见的抗生素耐药变体、广谱活性、低毒性和高特异性促使制药行业进行临床试验,将其开发为治疗药物。计算机辅助策略的快速发展加速了 AMPs 的鉴定。抗菌肽数据库 (APD) 迄今为止包含了来自不同来源的 3324 种 AMPs。除了在不同领域的应用外,一些 AMPs 显示出对抗 COVID-19 的潜力,并以多种方式阻碍病毒的感染力。
本文简要介绍了 AMPs 的历史及其特性,包括分类、进化、来源和作用机制、生物合成途径以及鉴定技术。此外,还介绍了它们的不同应用、临床应用的挑战以及它们在对抗 COVID-19 方面的潜在用途。